Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants'; the page's intervention labeling and related headers were updated (Intervention/Treatment added and Intervention / Treatment removed) as part of Revision v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-12T00:49:00.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Kharkiv Oblast location was added with the city Kharkiv, Kharkiv Oblast, Ukraine, 61070. The previous Kharkivs’ka Oblast’ entry (Kharkiv, Kharkivs’ka Oblast’, Ukraine, 61070) was removed.
    Difference
    0.0%
    Check dated 2026-06-05T00:18:01.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.5.3 to v3.5.4, indicating a backend or documentation update. The study content and user-facing information appear unchanged.
    Difference
    0.0%
    Check dated 2026-05-21T16:26:19.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The Taiwan site entry changes from Taoyuan District to Taoyuan, standardizing the city name in the study's locations. The postal code remains associated with the site.
    Difference
    0.0%
    Check dated 2026-05-07T09:45:21.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.5.2 to v3.5.3, indicating a newer version of the page documentation. The update does not modify study content or data.
    Difference
    0.0%
    Check dated 2026-04-30T08:50:06.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-15T22:06:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.